SGS - International Biopharmaceutical Industry

Current Edition

Issue 9, Volume 3

Current Features

Issue 9, Volume 3

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

news

SGS Increases Biosafety Testing Capacity at Its Glasgow Facility

SGS has just completed a significant expansion project at its Glasgow facility, meaning it can provide increased biosafety testing for the biologics, drug development...

28 October 2021 news biological medicines | cell therapy

Continue Reading →

A Global Approach to Nitrosamine Impurity Testing for Drug Products

Volume 3 Issue 3

A Global Approach to Nitrosamine Impurity Testing for Drug Products

Manufacturers and regulatory authorities around the world are now aware of the potential threat posed by nitrosamine impurities in API/DP. By taking a global, collabo...

10 December 2020 Volume 3 Issue 3 Nitrosamine | SGS

Continue Reading →